Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of engineering chemotherapy drug resistant T-cells for immunotherapy

Method of engineering chemotherapy drug resistant T-cells for immunotherapy

US Patent 10813951 · Granted Oct 27, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Targeted gene insertion for improved immune cells therapy2025
Targeted gene insertion for improved immune cells therapy2025
Method for improving production of car T cells2025
Method for generating t-cells compatible for allogenic transplantation2025
Method for generating t-cells compatible for allogenic transplantation2025
Targeted gene integration of CRS inhibitor genes for improved immune cells thera2025
Targeted gene integration of CRS inhibitor genes for improved immune cells thera2025
Targeted gene integration of NK inhibitors genes for improved immune cells thera2025
Targeted gene integration of NK inhibitors genes for improved immune cells thera2025
Cellular immunotherapy for repetitive administration2024
Cellular immunotherapy for repetitive administration2024
Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclea2024